Abstract | BACKGROUND: METHODS:
Oxaliplatin was injected intraperitoneally in mice. Cold allodynia was evaluated by the acetone test. Expression levels of TRPM8 mRNA and protein were measured using reverse transcription-polymerase chain reaction and Western blotting, respectively. RESULTS:
Oxaliplatin-induced cold allodynia was alleviated by the TRPM8 blockers N-(2-aminoethyl)-N-[4-(benzyloxy)-3-methoxybenzyl]-N'-(1S)-1-(phenyl) ethyl] urea and TC-I 2014. Oxaliplatin increased the expression levels of TRPM8 mRNA and protein in the dorsal root ganglia and plantar skin, respectively. Prophylactic administration of the c-Myc inhibitor 10058-F4 prevented cold allodynia and the increase of TRPM8 mRNA after oxaliplatin injection. CONCLUSION: These results suggest that oxaliplatin induces cold allodynia through the increase of c-Myc-mediated TRPM8 expression in primary sensory neurons.
|
Authors | Shizuka Mizoguchi, Tsugunobu Andoh, Takayuki Yakura, Yasushi Kuraishi |
Journal | Pharmacological reports : PR
(Pharmacol Rep)
Vol. 68
Issue 3
Pg. 645-8
(Jun 2016)
ISSN: 2299-5684 [Electronic] Switzerland |
PMID | 27031051
(Publication Type: Journal Article)
|
Copyright | Copyright © 2016 Institute of Pharmacology, Polish Academy of Sciences. Published by Elsevier Urban & Partner Sp. z o.o. All rights reserved. |
Chemical References |
- 5-(4-ethylbenzylidene)-2-thioxothiazolidin-4-one
- Benzyl Compounds
- N-(2-aminoethyl)-N-(4-(benzyloxy)-3-methoxybenzyl)-N'-(1S)-1-(phenyl) ethyl)urea
- Organoplatinum Compounds
- Proto-Oncogene Proteins c-myc
- TRPA1 Cation Channel
- TRPM Cation Channels
- TRPM8 protein, mouse
- Thiazoles
- Transient Receptor Potential Channels
- Trpa1 protein, mouse
- Oxaliplatin
- Urea
|
Topics |
- Animals
- Benzyl Compounds
(pharmacology)
- Ganglia, Spinal
(metabolism)
- Hyperalgesia
(chemically induced)
- Male
- Mice
- Organoplatinum Compounds
(antagonists & inhibitors, pharmacology)
- Oxaliplatin
- Proto-Oncogene Proteins c-myc
(antagonists & inhibitors)
- Skin
(metabolism)
- TRPA1 Cation Channel
- TRPM Cation Channels
(antagonists & inhibitors, biosynthesis)
- Thiazoles
(pharmacology)
- Transient Receptor Potential Channels
(antagonists & inhibitors)
- Urea
(pharmacology)
|